Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ugo Testa

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
Biomedicines|December 30, 2025
Gene Therapy of Beta HemoglobinopathiesUgo Testa, Elvira Pelosi, Germana Castelli
Hematology Reports|December 24, 2025
Clinical and Biological Insights into Myelodysplastic Neoplasms Associated with Deletions of Chromosome 5q RegionUgo Testa, Germana Castelli, Elvira Pelosi
Current Oncology (Toronto, Ont.)|December 27, 2024
Braf-Mutant Melanomas: Biology and TherapyElvira Pelosi, Germana Castelli, Ugo Testa
Cancers|August 29, 2024
CAR-T Cells in the Treatment of Nervous System TumorsUgo Testa, Germana Castelli, Elvira Pelosi
Cancers|November 9, 2024
Membrane Antigen Targeting in Acute Myeloid Leukemia Using Antibodies or CAR-T CellsUgo Testa, Germana Castelli, Elvira Pelosi
Biomedicines|July 29, 2023
Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid LeukemiasUgo Testa, Elvira Pelosi, Germana Castelli
Tumori|September 29, 2023
Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targetingUgo Testa, Germana Castelli, Elvira Pelosi
Expert Review of Anticancer Therapy|January 19, 2023
The clinical value of identifying genetic abnormalities that can be targeted in cholangiocarcinomasUgo Testa, Elvira Pelosi, Germana Castelli
Blood Cells, Molecules & Diseases|October 14, 2015
Targeting LSCs through membrane antigens selectively or preferentially expressed on these cellsElvira Pelosi, Germana Castelli, Ugo Testa
Medical Sciences (Basel, Switzerland)|November 22, 2017
Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating CellsUgo Testa, Germana Castelli, Elvira Pelosi
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Biomedicines|December 30, 2025
Gene Therapy of Beta HemoglobinopathiesUgo Testa, Elvira Pelosi, Germana Castelli
Hematology Reports|December 24, 2025
Clinical and Biological Insights into Myelodysplastic Neoplasms Associated with Deletions of Chromosome 5q RegionUgo Testa, Germana Castelli, Elvira Pelosi
Current Oncology (Toronto, Ont.)|December 27, 2024
Braf-Mutant Melanomas: Biology and TherapyElvira Pelosi, Germana Castelli, Ugo Testa
Cancers|August 29, 2024
CAR-T Cells in the Treatment of Nervous System TumorsUgo Testa, Germana Castelli, Elvira Pelosi
Cancers|November 9, 2024
Membrane Antigen Targeting in Acute Myeloid Leukemia Using Antibodies or CAR-T CellsUgo Testa, Germana Castelli, Elvira Pelosi
Biomedicines|July 29, 2023
Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid LeukemiasUgo Testa, Elvira Pelosi, Germana Castelli
Tumori|September 29, 2023
Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targetingUgo Testa, Germana Castelli, Elvira Pelosi
Expert Review of Anticancer Therapy|January 19, 2023
The clinical value of identifying genetic abnormalities that can be targeted in cholangiocarcinomasUgo Testa, Elvira Pelosi, Germana Castelli
Blood Cells, Molecules & Diseases|October 14, 2015
Targeting LSCs through membrane antigens selectively or preferentially expressed on these cellsElvira Pelosi, Germana Castelli, Ugo Testa
Medical Sciences (Basel, Switzerland)|November 22, 2017
Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating CellsUgo Testa, Germana Castelli, Elvira Pelosi
Pageof 17